The last BPSU survey was 25 years ago and we wished to update the data and find if there was a link between phenotype, ethnicity, location, and outcome.MethodsThe survey covered all children in the UK and Ireland who had a new diagnosis of KD between February 2013 and February 2015. ...
www.mayoclinic.com/health/kawasaki-disease/DS00576 Paediatric Rheumatology International Trials Organization (PRINTO) www.printo.it/pediatric-rheumatology/information/UK/6.htm Inform yourself To find this and previous JAMA Patient Pages, go to the Patient Page link onJAMA's website atwww.jama.com....
Kawasaki disease (mucocutaneous lymph node syndrome) was first described by Dr Tomisaku Kawasaki in 1967.1Since then, more than 100,000 cases have been reported worldwide, the majority occuring in Japan.2The disease predominantly affects young children and it is now the commonest cause of acquire...
Kawasaki Disease is associated with early and late coronary abnormalities. Coronary calcifications have been noted on long-term follow ups in the region of the initial abnormalities. We present the first case of an asymptomatic adolescent with Kawasaki Disease and normal stress testing in whom ...
Kawasaki disease is a medium-sized necrotizing febrile vasculitis that predominantly affects children < 5 years of age.
Kawasaki disease (KD) (see the image below) is an acute febrile vasculitic syndrome of early childhood that, although it has a good prognosis with treatment, can lead to death from coronary artery aneurysm (CAA) in a very small percentage of patients.{fi
Kawasaki disease (KD) is the second most common childhood vasculitis, after Henoch-Schonlein purpura, and predominantly affects children < 5 years of age [1, 2]. In view of the potential severity of the illness, [3] of its possible genetic background, and its unknown etiology, it is...
[9,10,11]. Recently, along with the COVID-19 pandemic, Kawasaki-like disease associated with COVID-19 has been increasingly reported. Large case series of KD related to SARS-CoV-2 from the United Kingdom (UK), Italy, the United States of America (USA), and France were published [6,...
Imperial College London is planning to market a low-cost COVID-19 vaccine via a social enterprise as early as next year. Royalties will be waived for the UK and low-income countries. Professor Robin Shattock from Imperial said in a statement: "These new enterprises are the most effective way...
Patients were prospectively recruited at pediatric centers in the United Kingdom, Spain, the Netherlands, and the United States if they had febrile illness and required blood testing for clinical investigation as part of the UK-based Immunopathology of Respiratory, Inflammatory and Infectious Disease ...